BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10912531)

  • 1. Molecular mechanisms of secondary hyperparathyroidism.
    Silver J; Kilav R; Sela-Brown A; Naveh-Many T
    Pediatr Nephrol; 2000 Jul; 14(7):626-8. PubMed ID: 10912531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate.
    Silver J; Yalcindag C; Sela-Brown A; Kilav R; Naveh-Many T
    Kidney Int Suppl; 1999 Dec; 73():S2-7. PubMed ID: 10633456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium, phosphate, vitamin D, and the parathyroid.
    Marks KH; Kilav R; Naveh-Many T; Silver J
    Pediatr Nephrol; 1996 Jun; 10(3):364-7. PubMed ID: 8792407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of increased parathyroid hormone mRNA in experimental uremia: roles of protein RNA binding and RNA degradation.
    Yalcindag C; Silver J; Naveh-Many T
    J Am Soc Nephrol; 1999 Dec; 10(12):2562-8. PubMed ID: 10589695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.
    Naveh-Many T; Rahamimov R; Livni N; Silver J
    J Clin Invest; 1995 Oct; 96(4):1786-93. PubMed ID: 7560070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD.
    Nechama M; Ben-Dov IZ; Silver J; Naveh-Many T
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F795-800. PubMed ID: 19129257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular mechanisms of secondary hyperparathyroidism.
    Silver J; Levi R
    Clin Nephrol; 2005 Feb; 63(2):119-26. PubMed ID: 15730054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of secondary hyperparathyroidism.
    Silver J; Kilav R; Naveh-Many T
    Am J Physiol Renal Physiol; 2002 Sep; 283(3):F367-76. PubMed ID: 12167586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism.
    Nechama M; Uchida T; Mor Yosef-Levi I; Silver J; Naveh-Many T
    J Clin Invest; 2009 Oct; 119(10):3102-14. PubMed ID: 19770516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease.
    Silver J; Levi R
    Kidney Int Suppl; 2005 Jun; (95):S8-12. PubMed ID: 15882315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate.
    Moallem E; Kilav R; Silver J; Naveh-Many T
    J Biol Chem; 1998 Feb; 273(9):5253-9. PubMed ID: 9478982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
    Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D and the parathyroid.
    Beckerman P; Silver J
    Am J Med Sci; 1999 Jun; 317(6):363-9. PubMed ID: 10372835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.
    Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ
    Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphate and the parathyroid.
    Silver J; Naveh-Many T
    Kidney Int; 2009 May; 75(9):898-905. PubMed ID: 19129794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of parathyroid hormone synthesis in chronic renal failure in rats.
    Fukagawa M; Kaname S; Igarashi T; Ogata E; Kurokawa K
    Kidney Int; 1991 May; 39(5):874-81. PubMed ID: 2067203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of AUF1 as a parathyroid hormone mRNA 3'-untranslated region-binding protein that determines parathyroid hormone mRNA stability.
    Sela-Brown A; Silver J; Brewer G; Naveh-Many T
    J Biol Chem; 2000 Mar; 275(10):7424-9. PubMed ID: 10702317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conserved cis-acting element in the parathyroid hormone 3'-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate.
    Kilav R; Silver J; Naveh-Many T
    J Biol Chem; 2001 Mar; 276(12):8727-33. PubMed ID: 11118432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the regulation of parathyroid hormone synthesis and secretion in chronic renal failure.
    Silver J; Moallem E; Kilav R; Epstein E; Sela A; Naveh-Many T
    Nephrol Dial Transplant; 1996; 11 Suppl 3():2-5. PubMed ID: 8840303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.